Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach

By Lon Hoi-Kei   Liu Dongyang   DuBois Debra   Almon Richard   Jusko William  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 6, 2013-12 ,pp. : 701-712

Springer Publishing Company

Access to resources Recommend Favorite

Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker

By  

Medicinal Chemistry, Vol. 9, Iss. 7, 2013-11 ,pp. : 993-998

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats

By Gao Wei   Bihorel Sébastien   DuBois Debra   Almon Richard   Jusko William  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 1, 2011-02 ,pp. : 143-162

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Strategies for Huntington's Disease: From the Bench to the Clinic

By S. Brocardo Patricia   M. Gil-Mohapel Joana  

Current Psychopharmacology, Vol. 1, Iss. 2, 2012-05 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite